Efficacy and tolerability of recombinant human endostatin in combination with platinum-based chemotherapy in patients with advanced non-small cell lung cancer

Trial Profile

Efficacy and tolerability of recombinant human endostatin in combination with platinum-based chemotherapy in patients with advanced non-small cell lung cancer

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Mar 2010

At a glance

  • Drugs Antineoplastics; Endostatin
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Mar 2010 Status changed to completed, as reported by a Simcere media release.
    • 03 Sep 2008 Interim results reported in a Simcere media release.
    • 03 Sep 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top